Access links:
CONTENT
Destacados
-
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
Elliott, J. H., Lynen, L., Calmy, A., De Luca, A., Shafer, R. W., Zolfo, M., Clotet, B., Huffam, S., Boucher, C. A., Cooper, D. A., and Schapiro, J. M.Aids 22, 2053-2067. IF: 5.842, Q: 1st. Virology
-
HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region
Senserrich, J., Pauls, E., Armand-Ugon, M., Clotet-Codina, I., Moncunill, G., Clotet, B., and Este, J. A.Virology. 372: 421-9
-
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Opravil, M., Sasadeusz, J., Cooper, D. A., Rockstroh, J. K., Clumeck, N., Clotet, B., Montaner, J., Torriani, F. J., Depamphilis, J., and Dieterich, D. T.J Acquir Immune Defic Syndr 47, 36-49.
-
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.Lancet. 371, 1417-26. IF: 28,638, Q: 1st. Medicine
